Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment”

Autor: Meijide Míguez, Héctor, Montes García, Iñaki, Ochando Gómez, Miguel, García Merino, Isabel M., Cano, Emilio L., De La Torre, Alejandro

Publikováno v: In Revista Espanola de Geriatria y Gerontologia May-June 2023 58(3):175-175

Cellular and Humoral Response, Six Months After Two Doses of BNT162b2 Messenger Ribonucleic Acid Coronavirus Disease 2019 Vaccination, in Residents and Staff of Nursing Homes for the Elderly.

Autor: Meijide Míguez H; Department of Internal Medicine, Hospital Quironsalud A Coruña, La Coruña, Spain., Ochando Gómez M; Clinical Laboratory, Health Diagnostic, Grupo Quironsalud, Madrid, Spain., Montes García I; Residencia Dulcinea, Grupo Quirónsalud, Ciudad Real, Spain., García Merino IM; Department of Research and Innovation, Grupo Quirónsalud, Madrid, Spain., De La Torre A; Clínica Imbanaco, Grupo Quironsalud, Cali, Colombia.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2022 Jan 18; Vol. 225 (2), pp. 355-357.